Suppr超能文献

葡萄糖转运蛋白 1(GLUT-1)的表达与局部晚期胃癌的肿瘤大小和预后不良相关。

Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer.

机构信息

Department of General Surgery, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China (mainland).

Department of Pathology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China (mainland).

出版信息

Med Sci Monit Basic Res. 2020 Mar 23;26:e920778. doi: 10.12659/MSMBR.920778.

Abstract

BACKGROUND The clinicopathological parameters associated with glucose transporter-1 (GLUT-1) expression in advanced gastric cancer are still controversial. This study aimed to determine the clinicopathological parameters and prognosis associated with GLUT-1 expression in advanced gastric cancer. MATERIAL AND METHODS The GLUT-1 expression level of 234 consecutive gastric cancer samples was detected by immunohistochemical staining and evaluated by semiquantitative analysis. The clinicopathological data and expression level of GLUT-1 of enrolled patients were retrospectively analyzed with univariate and multivariate analyses. RESULTS Tumor size, depth of invasion, and Lauren classification were independent factors related to GLUT-1 expression (P<0.05). Within advanced gastric cancer, tumor size and Lauren type were independent factors associated with GLUT-1 (P=0.011, P<0.001, respectively). The mean survival time of GLUT-1-positive patients with stage M0 advanced gastric cancer who had undergone radical gastrectomy was shorter than that of GLUT-1-negative patients (61.26±6.12 versus 80.88±7.38, P=0.044). GLUT-1 was an independent prognosis factor in locally advanced gastric cancer patients who had undergone radical gastrectomy (hazard ratio [HR] 1.769, P=0.046). The mean survival time of adjuvant chemotherapy was significantly better than no adjuvant chemotherapy in the GLUT-1-positive group (71.10±6.88 versus 24.65±8.69, P<0.001) and in the GLUT-1 negative group (87.48±7.99 versus 49.39±11.71, P<0.001). CONCLUSIONS Tumor size and Lauren type independently affected GLUT-1 expression in advanced gastric cancer. GLUT-1 was not only related to poor prognosis but also predicted to be a metabolic biomarker for intestinal type in locally advanced gastric cancer. The relationship among GLUT-1, hepatic metastasis and chemotherapy regimens, and mechanism of chemotherapy responses related to GLUT-1 should be further investigated.

摘要

背景

葡萄糖转运蛋白-1(GLUT-1)在晚期胃癌中的表达与临床病理参数的关系仍存在争议。本研究旨在确定与晚期胃癌中 GLUT-1 表达相关的临床病理参数和预后。

材料与方法

采用免疫组织化学染色法检测 234 例连续胃癌样本的 GLUT-1 表达水平,并通过半定量分析进行评估。回顾性分析纳入患者的临床病理资料和 GLUT-1 表达水平,并进行单因素和多因素分析。

结果

肿瘤大小、浸润深度和 Lauren 分类是与 GLUT-1 表达相关的独立因素(P<0.05)。在晚期胃癌中,肿瘤大小和 Lauren 分型是与 GLUT-1 相关的独立因素(P=0.011,P<0.001)。接受根治性胃切除术的 M0 期晚期胃癌 GLUT-1 阳性患者的平均生存时间短于 GLUT-1 阴性患者(61.26±6.12 与 80.88±7.38,P=0.044)。GLUT-1 是接受根治性胃切除术的局部晚期胃癌患者的独立预后因素(风险比[HR] 1.769,P=0.046)。在 GLUT-1 阳性组(71.10±6.88 与 24.65±8.69,P<0.001)和 GLUT-1 阴性组(87.48±7.99 与 49.39±11.71,P<0.001),辅助化疗的平均生存时间明显优于无辅助化疗。

结论

肿瘤大小和 Lauren 分型独立影响晚期胃癌中 GLUT-1 的表达。GLUT-1 不仅与预后不良相关,而且预测为局部晚期胃癌的肠型代谢生物标志物。应进一步研究 GLUT-1 与肝转移、化疗方案以及与 GLUT-1 相关的化疗反应机制之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb31/7115115/a30031ffc5bc/medscimonitbasicres-26-e920778-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验